CVE-2017-12712
The authentication algorithm in Abbott Laboratories pacemakers manufactured prior to Aug 28, 2017, which involves an authentication key and time stamp, can be compromised or bypassed, which may allow a nearby attacker to issue unauthorized commands to…
Does this matter?
High impact if exploited, but EPSS currently rates exploitation as unlikely (1.07%). Schedule it in the normal patch cycle and watch for a rise in EPSS or a public exploit.
Description
The authentication algorithm in Abbott Laboratories pacemakers manufactured prior to Aug 28, 2017, which involves an authentication key and time stamp, can be compromised or bypassed, which may allow a nearby attacker to issue unauthorized commands to the pacemaker via RF communications. CVSS v3 base score: 7.5, CVSS vector string: AV:A/AC:H/PR:N/UI:N/S:U/C:H/I:H/A:H. Abbott has developed a firmware update to help mitigate the identified vulnerabilities.
- CVSS 3.0
- 8.8 HIGHCVSS:3.0/AV:A/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:H
- EPSS
- 1.07% probability · 63th percentile
- CISA KEV
- Not listed
- Weakness
- CWE-287
- Affected
- abbott/accent firmware · abbott/anthem firmware · abbott/accent mri firmware · abbott/accent st firmware · abbott/assurity firmware · abbott/allure firmware · abbott/assurity mri firmware
- Source
- ics-cert@hq.dhs.gov
References
- http://www.securityfocus.com/bid/100523Third Party Advisory, VDB Entry
- https://ics-cert.us-cert.gov/advisories/ICSMA-17-241-01Third Party Advisory, US Government Resource
- http://www.securityfocus.com/bid/100523Third Party Advisory, VDB Entry
- https://ics-cert.us-cert.gov/advisories/ICSMA-17-241-01Third Party Advisory, US Government Resource
Source: NVD record, EPSS from FIRST.org, KEV from CISA. Refreshed daily.